Nc1c(C(=O)CSc2n[nH]c(-c3ccccc3Br)n2)c(=O)[nH]c(=O)n1C1CC1
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?